NDS

Workforce 2025: DISA's investment to meet 'pacing challenges'

Retrieved on: 
Thursday, June 1, 2023
Workforce, Defense Information Systems Agency, Heart, NDS, Defense, National Defense Strategy (United States), Multimedia, United States Joint Forces Command, GEORGE, DISA, Knowledge, Loes, Arms industry, Management

In support of the 2022 National Defense Strategy workforce requirements and to achieve its mission of connecting and protecting the warfighter in cyberspace, DISA announces a new initiative called Workforce 2025, fundamentally shifting the agency's training, recruiting and retention efforts.

Key Points: 
  • In support of the 2022 National Defense Strategy workforce requirements and to achieve its mission of connecting and protecting the warfighter in cyberspace, DISA announces a new initiative called Workforce 2025, fundamentally shifting the agency's training, recruiting and retention efforts.
  • "If we focus solely on the technology required to do this and forget about the people who operate it, we will become stagnant and outpaced."
  • Workforce 2025 is divided into four lines of effort to meet the NDS' call to attract, train and promote a workforce that is equipped with the knowledge and decision-making abilities to creatively solve national security challenges in a complex global environment.
  • For more information about Workforce 2025, including the four LOEs, click here .

Health Canada Accepts New Drug Submission for Lecanemab as Treatment for Early Alzheimer's Disease

Retrieved on: 
Tuesday, May 16, 2023
Priority review, The New England Journal of Medicine, Plaque, NDS, Alzheimer's disease, MHLW, Marketing, Neurotoxicity, Food, Advisory Committee, European Medicines Agency, Medicines and Healthcare products Regulatory Agency, Lecanemab, Ministry of Health, Labour and Welfare, Brain, Medication, Pharmaceuticals and Medical Devices Agency, Oncology Drug Advisory Committee, EMA, Clarity, Ministry, Eisai, The Different Forms of Flowers on Plants of the Same Species, Prescription Drug User Fee Act, PMDA, National Medical Products Administration, Co-promotion, PDUFA, Ministry of Health (Kuwait), MAA, AD, FDA, Phase, Health Canada, BLA, NMPA, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Disease, Medical imaging, Pharmaceutical industry, Biogen, Health

Lecanemab selectively binds and eliminates soluble, toxic Aβ aggregates (protofibrils) that are thought to contribute to the neurotoxicity in AD.

Key Points: 
  • Lecanemab selectively binds and eliminates soluble, toxic Aβ aggregates (protofibrils) that are thought to contribute to the neurotoxicity in AD.
  • As such, lecanemab may have the potential to have an effect on disease pathology and to slow down the progression of the disease.
  • The Clarity AD study of lecanemab met its primary endpoint and all key secondary endpoints with highly statistically significant results.
  • Lecanemab was approved under the accelerated approval pathway in the U.S. and was launched in the U.S. on January 18, 2023.

Health Canada Accepts New Drug Submission for Lecanemab as Treatment for Early Alzheimer’s Disease

Retrieved on: 
Tuesday, May 16, 2023
Priority review, The New England Journal of Medicine, Plaque, NDS, MHLW, Marketing, Neurotoxicity, Food, Advisory Committee, European Medicines Agency, Medicines and Healthcare products Regulatory Agency, Lecanemab, BIIB, Ministry of Health, Labour and Welfare, Brain, Pharmaceuticals and Medical Devices Agency, Medication, Oncology Drug Advisory Committee, EMA, Clarity, Ministry, The Different Forms of Flowers on Plants of the Same Species, Eisai, Prescription Drug User Fee Act, Headquarters, PMDA, National Medical Products Administration, Corporation, Co-promotion, PDUFA, Ministry of Health (Kuwait), MAA, AD, FDA, Phase, Health Canada, BLA, NMPA, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Disease, Pharmaceutical industry, Biogen, Health

Lecanemab selectively binds and eliminates soluble, toxic Aβ aggregates (protofibrils) that are thought to contribute to the neurotoxicity in AD.

Key Points: 
  • Lecanemab selectively binds and eliminates soluble, toxic Aβ aggregates (protofibrils) that are thought to contribute to the neurotoxicity in AD.
  • As such, lecanemab may have the potential to have an effect on disease pathology and to slow down the progression of the disease.
  • The Clarity AD study of lecanemab met its primary endpoint and all key secondary endpoints with highly statistically significant results.
  • Lecanemab was approved under the accelerated approval pathway in the U.S. and was launched in the U.S. on January 18, 2023.

The American Association of Naturopathic Physicians to Celebrate Naturopathic Medicine Week, May 14-20

Retrieved on: 
Friday, May 12, 2023
NDS, INM, Herbal medicine, Molina Healthcare, Public policy, Naturopathy, National University of Natural Medicine, United States Senate, US, Patient, Nature, Physician, Health, AANP, Pharmaceutical industry

WASHINGTON, May 12, 2023 /PRNewswire-PRWeb/ -- Naturopathic Medicine Week, an annual event held to promote the benefits of naturopathic medicine, is set to take place from May 14 to May 20, 2023. The week-long event aims to showcase the value of naturopathic medicine to patients, prospective patients, public policy makers, reporters, and community leaders through various creative activities, events, and messages.

Key Points: 
  • WASHINGTON, May 12, 2023 /PRNewswire-PRWeb/ -- Naturopathic Medicine Week , an annual event held to promote the benefits of naturopathic medicine, is set to take place from May 14 to May 20, 2023.
  • The origins of Naturopathic Medicine Week date back to 2013 when the US Senate unanimously passed S. Res.
  • The practice of naturopathic medicine includes modern and traditional modalities, and encompasses a range of therapies, including botanical and herbal medicine, nutritional medicine, lifestyle counseling, naturopathic physical manipulation, and much more.
  • The AANP encourages everyone to participate in Naturopathic Medicine Week 2023 and learn more about the benefits of naturopathic medicine.

Juvare Launches Juvare Federal and Defense

Retrieved on: 
Wednesday, April 5, 2023
Data Management, Technology, White House, Federal Government, Security, Homeland Security, Public Safety, Software, Other Defense, Defense, Contracts, Public Policy, Government, National Defense Strategy (United States), NDS, Security Strategy, Unitary state, United States Department of Homeland Security, ERP, Machine learning, JFD, FEMA, Growth, Federation, AI, Department of Defence, Online shopping, Renewable energy

The Board of Directors of Juvare, LLC today announced the establishment of the Juvare Federal and Defense (JFD) business unit to accelerate the delivery of technology solutions optimized for the U.S. Government to respond to crises and organize vital national security data.

Key Points: 
  • The Board of Directors of Juvare, LLC today announced the establishment of the Juvare Federal and Defense (JFD) business unit to accelerate the delivery of technology solutions optimized for the U.S. Government to respond to crises and organize vital national security data.
  • The USA-headquartered business unit will be led by Patrick Macfarlane, Chief Operating Officer and Patrick J.
  • JFD will leverage its independent operating model to bolster program delivery, aligning dedicated specialists and sales resources to enhance execution.
  • It has existing contracts with many departments including FEMA, Department of Homeland Security, and Department of Defense.

Nelnet Announces Reduction of Staff Due to Contract Changes Impacting Student Loan Servicing

Retrieved on: 
Thursday, March 23, 2023
NNI, Employment, NDS, Noordhoek, Risk, Federal Family Education Loan Program, Student, Security (finance), 1999 TransWorld Diversified Services Indy 200, NYSE, Bank, Nelnet

On March 22, 2023, Nelnet received a contract modification from the Department of Education (Department) for the company's current loan servicing contracts with the Department.

Key Points: 
  • On March 22, 2023, Nelnet received a contract modification from the Department of Education (Department) for the company's current loan servicing contracts with the Department.
  • Additionally, last month, the Department notified Nelnet of its intent to transfer 1 million borrowers from Nelnet Loan Servicing to another federal servicer.
  • Nelnet will also look for redundancies and efficiencies throughout the year related to the conclusion of projects centered on the consolidation of select loan servicing platforms.
  • Regarding its loan servicing systems, Nelnet continues to develop modern, innovative technology platforms to support federal and consumer loan servicing, respectively.

Intellias Expands in the Americas with New Offices in Bogotá, Colombia

Retrieved on: 
Tuesday, March 21, 2023
ISG, Semiconductor, Partnership, Renesas Electronics, NDS, Navigation Data Standard, CR7, SOC, Artificial intelligence, Growth, Mobility, ADAS, Airline, Satellite navigation device, Intellia Therapeutics, Delivery

CHICAGO , March 21, 2023 /PRNewswire/ -- Intellias, a major provider of consulting and software engineering services to the auto industry, is expanding in the Americas with a new development center in Bogotá, Colombia. 

Key Points: 
  • CHICAGO , March 21, 2023 /PRNewswire/ -- Intellias, a major provider of consulting and software engineering services to the auto industry, is expanding in the Americas with a new development center in Bogotá, Colombia.
  • Intellias currently has offices in Chicago and in Boca Raton, Florida.
  • Intellias opened new offices in Croatia, Bulgaria, Poland, Portugal and Spain and acquired Digitally Inspired, a fast-growing UK-based development company focused on retail and e-commerce business sectors.
  • For the Automotive Portable Kit, Intellias used SoC functionality for in-vehicle infotainment systems and an integrated digital cockpit.

Bright Data CEO Advises UK Politicians on Need for Industry-Led Public Web Data Regulation

Retrieved on: 
Tuesday, March 14, 2023
Data Management, Technology, Professional Services, Online Privacy, Other Technology, Data Analytics, Software, Artificial Intelligence, Public Policy, Government, Advocacy Group Opinion, Thought Leadership, Computer science, Ben Goertzel, University, UK Parliament Week, Research, Ernst & Young, University of Essex, All-Party Group for World Governance, UK Government Decontamination Service, Student, Ethics, Inquiry, Accenture, National Coding Week, University of Oxford, Government of the United Kingdom, Parliament of the United Kingdom, University of London, NDS, Electronic engineering, Russell Group, Lord Tim, Digital, Nursing, Tutoring

Or Lenchner, CEO of the industry-leading public web data platform Bright Data, last month joined members of the UK Parliament at a roundtable discussion looking at issues around ethics and regulation in data and alternative intelligence (AI).

Key Points: 
  • Or Lenchner, CEO of the industry-leading public web data platform Bright Data, last month joined members of the UK Parliament at a roundtable discussion looking at issues around ethics and regulation in data and alternative intelligence (AI).
  • He outlined how, as a responsible leader in the web data domain, Bright Data is taking steps to self-regulate and, hopefully, set ethical standards that point the way to effective regulation.
  • As one of the world’s biggest public web data platforms, Bright Data feels a sense of responsibility to help ensure that data is collected and used in the most ethical ways.
  • Participation in the Inquiry is a continuation of Bright Data’s support for the UK Government in implementing the National Data Strategy (NDS).

Nelnet Announces Changes to Staffing Capacity in Student Loan Servicing Division

Retrieved on: 
Wednesday, January 18, 2023
NDS, Education, NNI, Student debt, U.S. Department of Education, Office of Inspector General, NYSE, Office of Inspector General, U.S. Department of Health and Human Services, Bank, Nelnet

LINCOLN, Neb., Jan. 18, 2023 /PRNewswire/ -- Nelnet (NYSE: NNI) today announced changes to manage excess staff capacity due to delays in the government's student debt relief and return to repayment programs.

Key Points: 
  • LINCOLN, Neb., Jan. 18, 2023 /PRNewswire/ -- Nelnet (NYSE: NNI) today announced changes to manage excess staff capacity due to delays in the government's student debt relief and return to repayment programs.
  • Nelnet has a long history of providing high-quality, customer-focused student loan services—and having highly trained, qualified associates is a key component of that success.
  • Because of Nelnet's commitment to customers, its loan servicing centers have remained open and fully staffed throughout the pandemic and to date.
  • Nelnet remains committed to supporting the millions of federal student loan borrowers who will be entering repayment when the temporary pause ends later in the year.

REDUVO™ Marketing Approval on the Right Path

Retrieved on: 
Thursday, December 22, 2022
Tetra, Patient, Vomiting, Plasma protein binding, NDS, Health Canada, Weight loss, TSX, Insurance, TBP, Dronabinol, FRA, FDA, THC, Inflammation, Safety, Risk management plan, Risk management, HIV/AIDS, News, HIV, Multimedia, Cannabis, CINV, Pain, Nausea, Legislation, Physician, Research, Pharmaceutical industry

The Company will be submitting the response to Health Canada within the allowed timeframe.

Key Points: 
  • The Company will be submitting the response to Health Canada within the allowed timeframe.
  • Questions/feedback from Health Canada are received as the review of the dossier progresses through different review streams.
  • It is also used to treat weight loss and severe nausea in people living with HIV infection.
  • The active pharmaceutical ingredient in REDUVO™ is dronabinol, also known as THC, a synthetic form of the active natural substance in cannabis.